PTC Therapeutics, Inc. · NASDAQ:PTCT

PTC Therapeutics, Inc. financial statements

PTC Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.73B806.8M937.8M698.8M538.6M380.8M307.0M264.7M194.4M82.7M
Cost of revenue12.1M12.7M4.58M0
Gross profit294.8M252.1M189.8M82.7M
Research and development455.2M534.5M666.6M651.5M540.7M477.6M257.5M172.0M117.5M117.6M
Selling, general and administrative347.1M300.9M332.5M326.0M285.8M245.2M202.5M153.5M121.3M97.1M
Operating income866.9M-302.6M-439.5M-447.4M-374.4M-431.8M-241.2M-115.7M-64.3M-132.1M
Depreciation and amortization38.8M75.7M236.6M128.8M64.1M43.5M32.2M26.1M17.7M3.29M
EBITDA905.8M-226.9M-202.9M-318.6M-310.3M-388.3M-209.0M-89.6M-46.6M-128.8M
Income before tax696.6M-363.1M-696.1M-587.5M-518.3M-402.9M-239.9M-128.1M-77.7M-141.5M
Income tax14.0M176.0K-69.5M-28.5M5.56M35.2M11.7M-29.0K1.33M569.0K
Net income682.6M-363.3M-626.6M-559.0M-523.9M-438.2M-251.6M-128.1M-79.0M-142.1M
Earnings per share, basic8.58-4.73-8.37-7.79-7.43-6.64-4.27-2.75-2.02-4.17
Earnings per share, diluted7.78-4.73-8.37-7.79-7.43-6.64-4.27-2.75-2.02-4.17

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents984.6M779.7M594.0M279.8M189.7M208.8M288.0M169.5M111.8M58.3M
Short-term investments960.7M360.0M282.7M130.9M583.7M894.8M398.5M58.1M79.5M173.3M
Receivables181.6M158.6M160.8M155.6M110.5M69.9M55.5M67.9M40.4M24.9M
Inventory79.6M23.2M30.6M21.8M15.9M18.7M19.3M16.1M10.8M0
Current assets2.27B1.37B1.22B693.8M954.4M1.23B779.3M320.9M249.1M261.3M
Property, plant and equipment55.4M61.0M87.1M72.6M52.6M33.8M21.5M12.7M8.38M7.43M
Goodwill82.3M82.3M82.3M82.3M82.3M82.3M82.3M82.3M0
Total assets2.90B1.71B1.90B1.71B1.94B2.21B1.62B1.12B391.7M269.3M
Accounts payable45.5M17.3M6.04M27.3M23.0M18.7M10.3M6.00M15.3M6.30M
Current liabilities968.4M581.0M603.1M406.2M509.3M277.3M235.9M166.8M82.0M49.6M
Long-term debt285.4M284.2M571.7M281.9M309.1M293.9M141.3M145.0M98.2M
Total debt286.6M285.4M284.2M571.7M431.4M309.1M313.9M153.0M145.0M98.2M
Total liabilities3.10B2.80B2.71B2.05B1.94B1.73B1.03B768.5M235.2M149.8M
Shareholders' equity-205.3M-1.10B-818.6M-347.1M1.44M482.0M594.3M350.7M156.4M119.6M
Shares outstanding81.5M77.7M75.7M73.1M70.8M69.7M61.9M50.6M41.6M34.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations711.2M-107.7M-158.4M-356.7M-251.3M-194.1M-98.6M-27.6M-10.1M-103.6M
Capital spending-8.86M-6.50M-28.4M-32.0M-28.2M-17.8M-13.8M-7.10M-3.10M-1.78M
Free cash flow702.3M-114.2M-186.9M-388.7M-279.5M-211.9M-112.4M-34.7M-13.2M-105.3M
Cash from investing-862.0M44.2M-176.7M290.2M219.2M-561.5M-387.2M-42.6M13.1M104.5M
Cash from financing331.1M255.9M646.4M168.0M20.9M668.7M613.2M131.6M44.2M968.0K
Change in cash203.0M185.0M314.4M98.7M-19.1M-79.2M126.0M57.7M53.5M299.0K